- Home
- CPBI vs SEER Comparison
CPBI vs SEER Comparison
Compare CPBI & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPBI | SEER |
|---|---|---|
| Founded | 2023 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.4M | 97.3M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CPBI | SEER |
|---|---|---|
| Price | $21.00 | $2.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.6K | ★ 814.0K |
| Earning Date | 06-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.38 | ★ 9.40 |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | $53.74 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $15.56 | $1.55 |
| 52 Week High | $21.83 | $2.41 |
Technical Indicators
Market Signals| Indicator | CPBI | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 66.26 | 45.32 |
| Support Level | $16.88 | $1.81 |
| Resistance Level | $21.83 | $2.09 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 95.06 | 13.64 |
Price Performance
Historical ComparisonAbout CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans. The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans. The company's revenue is derived from the business of banking.
About SEER Seer Inc.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.